Latest Updates
Read the latest news that impacts the oncology community.
- Published On: August 30th, 2024
Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.
- Published On: August 30th, 2024
Four years ago, a team of researchers led by a heavyweight in the field of microbiology made a stunning claim: Cancers have unique microbial signatures that could one day allow tumors to be diagnosed with a blood test. The discovery captured the attention of the scientific community, as well as investors.
- Published On: August 30th, 2024
State legislatures are taking action to alleviate providers’ prior authorization struggles.
- Published On: August 30th, 2024
The Biden administration recently announced that it will use taxpayer dollars to “stabilize” Medicare Part D (prescription drug coverage) premiums.
- Published On: August 29th, 2024
WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) today is calling on the CEOs of three major Pharmacy Benefit Managers (PBMs)—CVS Caremark, Express Scripts, and Optum Rx—to correct the record for statements made during their appearance before the House Oversight Committee at a hearing titled, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.”
- Published On: August 29th, 2024
CHICAGO -- Congress must enact Medicare reforms aimed at addressing the steady decline in physician pay and reducing administrative hurdles by tying reimbursement to inflation, streamlining Medicare Advantage prior authorization, and exempting doctors with high approval rates from authorization requirements, new American Medical Association President Bruce Scott told Inside Health Policy in an exclusive interview.
- Published On: August 29th, 2024
In their ongoing quest to lower prescription drug prices, some states are forcing drugmakers to continue to sell cheaper medications to thousands of pharmacies through a federal drug-discount program.
- Published On: August 29th, 2024
Illumina has secured an FDA approval to bring its pan-cancer tissue profiling test to U.S. shores.
- Published On: August 29th, 2024
It’s no secret that prescription drugs are unaffordable for many Californians. In just five years, spending on prescription drugs ballooned from $8.7 billion to $12.1 billion, an increase of 39%, according to the most recent state data.
- Published On: August 28th, 2024
Health care costs are going up fast, and it's hurting everyone. But if we take a close look, we can see that just a few big companies are the main reason for this.